Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations

v3.25.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenue:        
Total revenue $ 8,861 $ 8,122 $ 26,561 $ 23,619
Cost of revenue 3,261 3,275 10,273 9,259
Gross profit 5,600 4,847 16,288 14,360
Research and development costs 3,452 3,315 10,660 9,060
Sales and marketing expenses 3,838 3,549 11,691 10,673
General and administrative expenses 3,586 3,141 11,056 8,725
Operating loss (5,276) (5,158) (17,119) (14,098)
Other income (expense):        
Other expense, net (64) (11) (112) (32)
Interest (expense) income, net (543) 209 (472) 646
Net loss before income taxes (5,883) (4,960) (17,703) (13,484)
Income tax expense (8) (14) (51) (44)
Net loss $ (5,891) $ (4,974) $ (17,754) $ (13,528)
Net loss per share attributable to common stockholders:        
Basic (in dollars per share) $ (0.21) $ (0.18) $ (0.63) $ (0.5)
Diluted (in dollars per share) $ (0.21) $ (0.18) $ (0.63) $ (0.5)
Weighted average shares outstanding:        
Basic (in shares) 28,427,574 27,591,623 28,137,528 26,840,119
Diluted (in shares) 28,427,574 27,591,623 28,137,528 26,840,119
Product revenue        
Revenue:        
Total revenue $ 5,361 $ 5,474 $ 16,649 $ 14,053
Service and other revenue        
Revenue:        
Total revenue $ 3,500 $ 2,648 $ 9,912 $ 9,566